Indian Medical Technology & Diagnostic Market need Innovations, access,availability and affordability. Indian Challenge is the penetration to the untapped & unorganised rural market : Dr G.S.K. Velu

Indian Medical Technology & Diagnostic Market need Innovations, access,availability and affordability. Indian Challenge is the penetration to the untapped & unorganised rural market : Dr G.S.K. Velu

Eminent Medical Technologist & Visionary Dr G.S.K. Velu of Trivitron Group receives rare recognition at Pharmaleaders 2013 Meet

 

Thursday, January 09, 2014,Mumbai,Maharashtra,India. Innovations are required in Smaller towns,cities, rural areas – largely untapped – disruptive, frugal innovations to improve access, availability, and affordability of Healthcare to address enormous Challenges in India.While Challenges exists in all four critical sectors such as pharmaceuticals, healthcare services medical education & medical technology, Medical Technology  remains the most neglected segment in India said Dr G.S.K. Velu,Founder Chairman of Trivitron Group Companies at the historic 6th Annual Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2013 held at Mumbai on 27th December .The 6th Annual Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards 2013 ( www.pharmaleaders2013.com  ) organized by illustrious Network 7 Media Group’s Pharmaleaderstv, Asia’s most analytical news media in healthcare communications ( www.pharmaleaders.tv  ) under the theme “Incredible Pharmaleaders 2013, Billion Dreams – Pushing India’s Growth Agenda” was successfully organized at Mumbai on 26th December 2013 with several leading national & global brands in pharmaceuticals & healthcare were felicitated & recognized for their outstanding contribution to the healthcare industry & medical profession by the eminent jury members of Network 7 Media Group. More than 300 professionals of the healthcare industry & medical experts attended to the historic global platform.

Taking the exceptional & remarkable progress by the young & dynamic visionary chairman of  Dr G.S.K. Velu of Trivitron Group of Companies initiatives & foray in medical technology & diagnostic industry, the jury member of the Network 7 Media Group & Pharmaleaders comprising of eminent personalities in public life, the consensus reached at honoring Dr G.S.K. Velu for his pioneering work in original innovation & taking the brand india’s image to the global platform. While the coveted “Entrepreneur of the year  2013 Award” was conferred to Dr. G.S.K. Velu for achieving rare success at the younger age in providing exceptional directions to the group companies leading from the front, Dr Velu’s pet outfit Medfort Maxivision Hospitals was declared winner in the coveted “Emerging Hospital Group 2013” category. Mayank Gandhi, Member National Executive, Aam Admi Party accompanied by the Editor-In-Chief of the Pharmaleaders Satya Brahma conferred the prestigious & coveted recognition to the first generation entrepreneur.

In a release to media, Dr G.S.K. Velu of Trivitron Group of Companies said “Trivitron Group is well-set to triple its manufacturing business  across different geographies within next 4 years & growing focus on innovation that helps build  range of products at affordable price. India can be a Global Med Tech Hub like Pharma with the right Eco System. Single Speciality Healthcare Services have a unique relevance owing to economies of scale and out-of-hospital convenience. Innovations in these areas will help achieve Health Security for All by 2020. I am  humbled by this rare & prestigious recognition & I accept this honour on behalf of 1000 employees”. 

In the key note address to the healthcare experts, policy makers & medical professionals & academician who were present at the 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2013 in the evening session, visionary Dr G S K Velu flabbergasted the delegates on the much awaited talk on Innovation and Advancements in Medical Devices and Single Specialty Healthcare Services – An India  Perspective as he emphasized that the Indian Medical technology, expertise and quality healthcare is set to grow phenomenally in next 5 years ahead of Japan & United States.

Creating the Largest Medical Technology company of Indian Origin, Dr Velu stressed that the Indian Medical Technology  Market is presently at approx. USD 5 Billion contributes to less than 2% of Global Market CAGR 4.4% & 60 % Revenue in Top 4 Medical Technology Segments coming  from  Medical Imaging, In Vitro Diagnostics, In Vitro Cardiology Diagnostics& Gastroenterology. Innovations are required in all four segments of Healthcare to address enormous Challenges in India & while challenges exists in all four sectors, Medical Technology  remains the most neglected segment in India.The Market Size of the Indian medical technology from  325 Billion USD  in 2012 is expected to cross  the Market Size 448 Billion USD in 2017. India is uniquely placed as it has huge market with increasing middle class population & growing private hospital sector providing improved accessibility, Increased Government Spending Planned by State and Central Government, Overseas companies investing in India to set up R & D units, Increasing Joint ventures and agreements, Overseas aid assisted projects to improve healthcare infrastructure, Regulations to improve market for domestic manufacturers, India can be a Global Med Tech Hub like Pharma with the right Eco System,Single Speciality Healthcare Services having a unique relevance owing to economies of scale and out-of-hospital convenience & only Innovations in these areas will help achieve Health Security for All by 2020. However India’s growth trajectory can lose its gear due to Low per capita expenditure,Developing government policies and infrastructure,Large population having low affordability,Lack of indigenous manufacturing,Academic know-how is not well developed in this sector,Support system for R & D not available Regulatory policies may slow down the development of the market,Unorganized market for medical disposables,Lack of regulations, specifications - leading to spurious products,Implementation Western  Regulatory systems blindly  may slow down access and affordability  in rural areas

To the credit of Dr Velu, the notable achievement includes Process 100 Million tests a year, Caters to more than 10,000 laboratories, hospitals & nursing homes,Assists 20,000 consultants,Market Leader in South and West India,Over 85 state-of-art-laboratories 1400 Collection Centers across India, Middle East & Africa,Direct Laboratory Presence in over 15 countries in South Asia, Middle East and Africa,NABL and,or CAP Accreditation for all Central Lab facilities,Technology leader encompassing all IVD technologies with over 4000 variety of investigations,India's Most Reputed Multinational Chain of Diagnostic center with direct laboratory presence in over 15 Countries,Strategic Minority Private Equity Investment by Warbug Pincus Capital,Best Diagnostics Service Provider in India in 2009 - Frost & Sullivan.  As a Pioneers in Eye Care Technology who introduced LASIK SURGERY IN INDIA in 1996, A Medfort  Initiative, National chain of Eye care and Diabetic Daycare Hospitals,15 State of the Art Eye Hospitals in 5 Cities operational . Plans 20 cities presence by 2015 ,State-of-the-art facilities for Diagnostics, Treatment, Surgery and MR, Victus Femtosecond Laser Cataract Technology –A  100% Hands Free, Blade-Free Technology, 1,80,000 Ocular Surgeries performed so far, 24,00,000 patients screened and treated so far & US-FD, CE approved Technologies

A first generation entrepreneur of over 25 years of experience in healthcare segment, who changed the way the medical technology and diagnostics industry works today, bringing them within the reach of medical practitioners across India, Dr Velu,Founder and Managing Director, Trivitron Group of Companies (the largest medical technology company of Indian origin) & Co Founder and Vice Chairman, Metropolis Healthcare(one of the largest diagnostic laboratory chains in Asia),Founder and Chairman, MedfortHospitals( a network of diabetes care and vision care hospitals),Founder and Director, Alliance Medicorp (Chain of dialysis and dental care) did his education in  Bachelor's degree in Pharmacy from the Birla Institute of Technology and Science (BITS), Pilani, MBA from Loyola Institute of Business Administration and a Doctorate from IBAM, Kolkata he worked with different global organizations gaining experience in medical technology. In 1997, Trivitron was founded by Dr.Velu and tied up with several world leaders in medical technology to cater to over 20 medical specialties across India. He also established the Trivitron Medical Technology Park, South Asia's first state-of-the-art medical technology manufacturing facility and the Trivitron Innovation Center, a center of excellence for biomedical research & development and design at IIT Madras.

A visionary, Dr. Velu changed the diagnostics field from a highly fragmented industry that served as purely backhand function, into one that plays a leading role in healthcare today. His efforts united leading diagnostics laboratories across the country under the Metropolis banner to set the highest standards of service.His latest venture Medfort is a chain of single specialty ambulatory care hospitals across the country that will soon link some of the nation's best doctors and technicians with cutting edge technology and international accreditation ensuring that patients get the very best care while continually setting the bar higher in terms of consistent healthcare delivery.

About Dr G S K Velu’s Trivitron Group Companies

• ü  Largest Medical Technology Company of Indian Origin
• ü  A multi-modality product company offering products/ solutions / services that are affordable and accessible by the entire population class
• ü  8manufacturing facilities that are GLP, GMP certified and spread across Chennai, Mumbai, Pune and Finland, marking our local and international presence
• ü  Deployment of state-of-the-art concepts like lean manufacturing, frugal engineering to reduce overall manufacturing costs helping us retain a competitive edge.
• ü  Products manufactured through synergies with local and global manufacturers are sold to the local markets and exported to over 165 countries.
• ü  5 innovation centres in partnership with India’s leading technical and medical education institutes backed with state-of-the-art technologies
• ü  20 % of the revenues invested in R&D to bring forward products that are of low cost, functionally better and technologically superior
• ü  12 Warehouses ensuring finest inventory management through processes that prescribe to automation across the entire value chain
• ü  25 offices
• ü  1000 employees
• ü  160  countries
• ü  12 warehouses
• ü  8 manufacturing  facilities
• ü  5 innovation centres
• ü  1,200 channel partners
• ü  35,000+ installations
•  

Noted Cosmetic Dermatologist Dr. Chytra.V.Anand storms into Pharmaleaders Powerbrand 2013,Voted as "India's Most Respected Cosmetic Dermatologist 2013"

Noted Cosmetic Dermatologist Dr. Chytra.V.Anand storms into Pharmaleaders Powerbrand 2013,Voted as "India's Most Respected Cosmetic Dermatologist 2013"

Kosmoderma Founder Dr. Chytra.V.Anand crowned the coveted Award for skincare innovations, Aesthetic Medicine services, , Ethical Medical Practices, Standard Operating Protocols, Quality Systems & building first Indian skincare clinic to innovate MediSpa concept

Monday,6^th January 2013,Mumbai, Maharashtra,India : The chase to select the best out of the best & select the brand & name that mattered most in the ever evolving & growing skincare practice in india ended at the Asia’s most awaited 6^th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2013 organised by the illustrious Network 7 Media Group’s Pharmaleaders Magazine (www.pharmaleaders.tv ), Asia’s most analytical news media in healthcare communications on Friday, 27^th December 2013 in the commercial capital of India. Dr. Chytra.V.Anand, Founder, CEO & Chief Cosmetic Dermatologist of Kosmoderma Skin & Laser Clinic was declared winner in the category of "India's Most Respected Cosmetic Dermatologist 2013" ending the suspense wChytrae 3 million people in 22 states in tier 1 & tier 2 cities in the various sections of india voted to chose the winner in nomination to the top five well known Cosmetic Dermatologists in India.

Noted Cosmetic Dermatologist Dr. Chytra.V.Anand storms into Pharmaleaders Powerbrand 2013,Voted as "India's Most Respected Cosmetic Dermatologist 2013"

In the nomination category were the five finalists such as Dr. Malavika Kohli, CEO & Founder, Skin secrets, Dr. Apratim Goel, CEO & Founder, Goel's Cutis Skin Studio, Dr. Chetana Kumar, Director, Laser Cosmetics, Dr. Shuba Dharmana, CEO & Founder,Le'jeune Medspa & Dr.Chytra V Anand, Founder, CEO & Chief Cosmetic Dermatologist of Kosmoderma Skin & Laser Clinic, shortlisted by the Network 7 Media Group’s esteemed panel members & furtChytra approved by the Pharmaleaders jury members. Dr.Chytra V Anand not only pulled larger number of votes via sms, email & physical interviews that were conducted to access the mood of the nation by the Network 7 Media Group, Chytra also received maximum votes by the independent jury in the final stage. The historic 6th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2013 was attended by more than 300 delegates that comprised of top doctors, executives from the healthcare companies & policy makers. Mayank Gandhi, Member National Executive, Aam Admi Party accompanied by the Editor-In-Chief of the Pharmaleaders Satya Brahma & Anjali Damania,Convenor of Maharashtra Aam Admi Party conferred the prestigious & coveted recognition to the India’s Most Respected Cosmetic Dermatologist 2013. Dr.Chytra V Anand  in a power packed glittering award evening.   

Elated & Excited to hear Chytra name at the stage, Dr.Chytra V Anand said “ This recognition means a great degree of honKosmoderma & prestige as the award methodology & selection criteria was credible & my responsibilities increase manifold with this rare recognition & it will motivate my mission to achieve path breaking research in skincare innovations currently undergoing at my firm Kosmoderma”.

Cosmetic Dermatology is an ever-evolving field of science that is non-essential medicinal service. The idea of beautification , moulding , creating, the artistry and skill level involved to be cutting edge in this field is an exciting prospect in itself… To make this art and science combination available to the Indian masses at affordable pricing and at the same time not compromise on the quality of care and medical ethics is what drives me. My vision is to make Kosmoderma Clinics the Gold standard & trendsetter in Aesthetic Medicine& Cosmetic Dermatology. This is my dream and this has set me on my path of pursuit towards providing the best Cosmetic Dermatology services in India equivalent if not superior to that found abroad and on the world platform for such services, Dr Chytra added.

Currently I am leading my team to open Kosmoderma centres of excellence across India, in Chennai, Hyderabad, Mumbai and Delhi. I have a vision of 3 centres per Tier 1 city and 1 centre per tier 2 city.  I am excited to see Kosmoderma evolving from a Cosmetic Dermatology practice to a one-stop wellness centre with integration of Nutrition, Cosmetic Surgery and Rehabilitative Skin & Hair Medicine. To reach the grass roots and offer Kosmoderma services across India, we are in the midst of developing a Kosmoderma Associate Physician program, wChytrae dermatologists are offered special training in cosmetic dermatology at Kosmoderma Academy and then without having to invest heavily into all equipment’s, are able to refer patients to Kosmoderma centres of excellence at various cities. This way we are able to reach all levels of Indian clientele and offer safe effective reasonable priced procedures without compromise on technology or quality of care. As part of my endeavKosmoderma to provide the best Cosmetic Dermatology, Aesthetic Medicine services, I have been involved in research of skincare suitable for Indian skin since 2008 and currently have 14 products in the Kosmocare range and am working on research to furtChytra develop scientifically proven, effective skincare for the Indian skin that every Indian or person of colKosmoderma can use safely. I am currently running trials on 4 new products that are meant for effective sun protection to decrease skin damage. Currently these are available at Kosmoderma Clinics and at select leading Cosmetic Dermatologists. In future Kosmocare will be available online post a skinscription by Skype from Kosmoderma doctors and Kosmoderma affiliate program.

I love training doctors to bring them to par with international standards as after being educated in India and in UK & USA, I found that though we are brilliant people, Kosmoderma education standards are not up to par with the West... So in 2007 I started a training academy IAAM to train doctors to bring them up to par with the western doctors in the field of Aesthetic Medicine & Cosmetic Dermatology. After having personally trained over 550 doctors this is a driving passion for me to make sure that all Kosmoderma doctors have a fair playing field and that the global perception of Indian Cosmetic Dermatologists changes.

Kosmoderma is dedicated to medical excellence in the field of Cosmetic Dermatology, with international accreditations and facilities, offering scientifically proven treatments using US FDA & European CE approved technology.

All Kosmoderma products have undergone extensive research and trials. We strive towards technical excellence and are constantly updating Kosmodermaselves so as to deliver world class cutting edge technology to Kosmoderma clients every day. Kosmoderma Aim is to offer result oriented, safe and effective treatments with high standards of quality with exceptional care and service and make it affordable to the Indian consumer.Kosmoderma is proud to have pioneered the first state of art clinics dedicated solely to Cosmetic Dermatology and Medical Aesthetics in Bangalore back in 2006, currently with 5 branches across Bangalore, 1 in Hyderabad with staff strength of 50+. The recent JVs between Kosmoderma and otChytra healthcare providers will see the opening of Kosmoderma Skin Clinics inside specialist healthcare centers across the country starting with Chennai, Mumbai, Pune and Delhi.

Dr Chytra V Anand founded Kosmoderma Clinics in 2006 as a one person operation with the vision to create an enterprise, which quickly grew to have 3 employees. In 2007 Chytra opened the 2nd clinic in Indianranagr Bangalore and the team grew to a size of 7. In 2008, the flagship in Lavelle Road was opened with the company strength growing to 15. Recognising the need to spread the availability of services across the city and to be avilable to the people, the 3rd clinic was opened in Whitefiled area in 2010 and a 4th centre of excellence at JP Nagar in 2012. The team grew incorporating Dermatologists, Aesthteic Physcians and Medical Aestheticians and the entire area of Bangalore is now covered.

As CEO, Chytra is involved with overseeing the growth of the company and maintaining of quality. Chytra heads a team of 50+ and leads them to excel on a daily basis. As a Consultant dermatologist Chytra consults patients at Kosmoderma Clinics and is sought after from patients across the world and all walks of life.After years of research by Dr Chytra, Kosmoderma has its own in house skin care brand Kosmocare. This has entered Kosmoderma into the FMCG market segment.

Under Chytra’s  guidance, expansion plans are underway to have a flagship clinic in every metro within a year from now and a pan India presence of 25 clinics within the next 3 years. Kosmoderma will achieve this with strategic partnering with otChytra healthcare brands who like us have a vision of providing speciality healthcare services and a mission to aggressively cover the subcontinent in a very short time span catering to the needs of the masses who demand the latest treatments and best of services in terms of healthcare. Recognising E-commerce, from Jan 2014 Kosmoderma will be offering skype consults and online sale of Kosmocare.

Kosmoderma is the first Indian Cosmetic Dermatology centre to have its own app (Acne app) available to help acne prone individuals developed personally by Dr Chytra and Chytra team.In summary: Dr Chytra Anand is the CEO of the Company. Chytra plays a pivotal role in strategy, business growth and Quality of Services & Outcome Standalone clinics, Strategically Partnered clinics, Branded skin care products, Leveraging Information Technology are strategic and business growth outcomes from Chytra efforts.

Service Manuals, Ethical Medical Practices, Standard Operating Protocols, Quality Systems are outcomes arising from Chytra passion to quality of service and outcomes From 2006 to 2013, Kosmoderma has grown from 1 clinic, 1 person to 6 clinics with a team of 50+ under the guidance of Kosmoderma CEO Dr Chytra V Anand. Chytra vision to make Kosmoderma a team work based enterprise as opposed to single person entity has seen Chytra create an outstanding team of leaders and an enterprise par excellence.

Keeping with the philosophy of spreading knowledge, in 2007, Dr Anand founded the International Academy of Aesthetic Medicineto train doctors in the field of Cosmetic Dermatology as Chytra realized that doctors in India did not have enough exposure to Cosmetic Dermatology in regular practice and required additional specialized training. Under Chytra guidance the academy conducts intensive hands on training cKosmodermases for doctors from around the globe. Chytra has personally trained over 750 doctors in Aesthetic Medicine procedures at Chytra academy and is credited with pioneering Aesthetic Medicine & Cosmetic Dermatology training in India. The Academy has attracted students from India, UK, Sri Lanka, Europe, Dubai, Africa, Singapore, Thailand and Malaysia and is considered a top-notch training facility.

In 2010, keeping with the international trend, Kosmoderma launched the MediSpa concept. Under this beauty was merged with medicine to provide maintenance services for skin, hair and body. It was the first of its kind in India.

In 2012, Kosmocare a skin care brand made by a FDA approved lab in Thailand and a GMP approved lab in India. Currently tChytrae are 14 products in the range and trials for 6 more are currently underway, with 5 more formulations under research. This is now a business vertical for Kosmoderma.Realising the necessity to grow at a quicker pace without seeking external funding yet, strategic partnerships have been formed with otChytra healthcare providers like MotChytrahood a VC funded 150 Cr company that is in the process of expansion across South India in the IVF, birthing sector wChytrae Kosmoderma is opening a shop in shop model to provide services in Chennai & Hyderabad. Realising the importance of being available to the masses, Kosmoderma has partnered with Express Clinics a primary healthcare provider with 6 outlets in Bangalore, 10 each in Pune, Mumbai and Delhi to provide Dermatological and Cosmetic Dermatology services at its centre on an out sKosmodermaced basis. With this Kosmoderma will forray into Pune, Mumbai & Delhi sectors.

With these 2 strategic Healthcare Partnerships, Kosmoderma will have a pan Indian presence by 2014 end.In Nov 2013, a centre dedicated to pregnant and lactating women and women with hormonal imblanaces was opened at CMH road to specially cater to this segement with specialised services incorporating allopathy, Ayurveda and homeopathy.In 2013 Kosmoderma Academy was launched for dedicated constant training of Kosmoderma staff and regular updates to maintain standardised quality across all centres.With increase in dollar rate vs Rs, the Indian dermatological climate changed with doctors compromising on quality and purchasing cheaper non FDA , CE approved lasers to cater to the demand leading to inferior results. To try to curb this dilution of quality and to bring in a wider network of doctors under the Kosmoderma umbrella, the Kosmoderma Affiliate , Associate Program has been launched, wChytrae dermatologists and allied physicians like OBGYN, Endocrinologists and GP’s refer their patients to Kosmoderma for Cosmetic Dermatology services. The dermatologists are provided specialised training at Kosmoderma Academy and their patients are treated for them by Kosmoderma staff. Thus dermatologists who are unable to invest into their equipments are able to use Kosmoderma services and still be independent practitioners. Through this venture we have been able to offer quality care without the dermatologists having to turn towards non FDA,CE approved technology and extend the reach of Kosmoderma to a wider audience. This has increased Kosmoderma referral rate and added to revenue of the company and increased Kosmoderma target audience reach. Realising the potential on internet, Kosmoderma is the first Cosmetic dermatology company in India to offer an app service for acne patients. Using this app, acne patients can keep abreast of the latest in the developments in acne therapy. It is currently available for androids and the IOS version will soon be launched.

Dr Anand’s pet project is to standardise and regulate the cosmetic dermatology industry to prevent quackery and abuse of this medical field by non-qualified personnel. She is consulting with deemed universities in Karnataka to create a Diploma Course in Aesthetic Medicine for postgraduates to better prepare the doctors for practise in the Cosmetic industry. She is currently working on a course curriculum for doctors, nurses, and aestheticians. The aim is to introduce these courses from 2015. She has sent a proposal to the Karnataka Govt to regulate the Cosmetic dermatology sector through the Karnataka Medical Council and Health Ministry.

Noted Surgical Gastroenterologist & Global Hospitals Founder Dr. Kancherla Ravindranath crowned at 6th Annual Pharmaceutical Leadership Summit & Awards 2013

Noted Surgical Gastroenterologist & Global Hospitals Founder Dr. Kancherla Ravindranath crowned at 6th Annual Pharmaceutical Leadership Summit & Awards 2013

Dr. Kancherla Ravindranath led Global Hospitals Group voted India’s Best Managed Healthcare Chain 2013 & Founder Dr. Kancherla Ravindranath awarded Healthcare Visionary of The Decade in individual Jury

Thursday, January 02, 2014, Mumbai, Maharashtra, India. 6th Annual Pharmaceutical Leadership & Pharmaleaders Business Leadership Awards 2013 ( www.pharmaleaders2013.com ) organized by illustrious Network 7 Media Group’s Pharmaleaderstv, Asia’s most analytical news media in healthcare communications ( www.pharmaleaders.tv ) under the theme “Incredible Pharmaleaders 2013, Billion Dreams – Pushing India’s Growth Agenda” was successfully organized at Mumbai on 26th December 2013 with several leading national & global brands in pharmaceuticals & healthcare were felicitated & recognized for their outstanding contribution to the healthcare industry & medical profession by the eminent jury members of Network 7 Media Group. More than 300 professionals of the healthcare industry & medical experts attended to the historic global platform.

Dr. Kancherla Ravindranath led Global Hospitals Group voted India’s Best Managed Healthcare Chain 2013 & Founder Dr. Kancherla Ravindranath awarded Healthcare Visionary of The Decade at the glittering award ceremony. While Dr Ravindranath was voted by the jury members of the Network 7 Media Group in an individual category, Global Hospitals Group received the rare distinction of winning the coveted & prestigious “India’s Best Managed Healthcare Chain 2013” by the people of india in the voting category after reaching to the top five finalists declared by the jury members of Pharmaleaders Group. Global Hospitals Group received the maximum number of votes of a sample size of 5 million votes that were thrown to public for voting via sms,email & physical interviews conducted by the Pharmaleaders media in 22 states & 5 Nations. Global Hospitals Group emerged out as a clear winner beating the biggest healthcare chains in india & abroad such as Apollo Hospitals Group, Fortis Healthcare, Care Hospitals, Manipal Hospitals Group. At a time when Healthcare Innovations in india is struggling to make its impact due to regulatory constraints, lack of healthcare insurance & high cost of infrastructure & consultant’s professional fees, Global Hospitals is clearly not compromising in quality healthcare & carved out a niche for itself in the Managed Healthcare added Satya.

“The rise of Global Hospitals Group in India having its presence in Hyderabad,Mumbai,Bengaluru & Chennai with world class specialized medical aid in areas ranging from diagnosis to multi-organ transplantation, from simple procedures to complex surgeries, international expertise and state–of-the-art infrastructure caught the attention of the people’s mind while voting” said Satya Brahma, Chairman & Editor-In-Chief of Pharmaleaders Group. Global Hospitals is India's leading and the fastest growing super specialty care and multi-organ transplantation hospital. Pioneers in performing transplantation surgeries, Global Hospitals has to its credit many trailblazing achievements made possible by combining research, teaching and patient care.

In a communication to Pharmaleaders, Dr. Kancherla Ravindranath, CMD, Global Hospitals Group said “ Global Hospitals Group is the creation of meeting the complex medical treatments of the people of india & providing world-class medical services with latest infrastructure in our each Hospitals, I feel humbled & elated to receive the award from the Pharmaleaders Jury specially when people of india voted us as India’s Best Managed Hospital Chain”. 

Dr. Kancherla Ravindranath, is a world-renowned expert in Surgical Gastroenterology, and the founder of Global Hospitals Group – acknowledged as India's fastest growing chain of tertiary care multi super specialty hospitals. Under Dr. Ravindranath's visionary leadership and guidance, Global Hospitals Group has become the premier and niche healthcare center that is in to performing high-end surgeries, such as the first ever liver, heart, twin kidney and bone marrow transplants in Andhra Pradesh and multiple such cutting edge and pioneering surgeries in India. Currently, with eight world class tertiary care Hospitals in Chennai, Bengaluru & Hyderabad, and soon Mumbai centre opening up, today Global Hospitals has grown to be acknowledged as the world's most comprehensive centre for Liver & Pancreas Diseases and Transplantation. While working in some of UK's top medical institutions, witnessing the hardships of Liver transplant patients and their painstaking ordeal, spending huge amounts of money, Dr. Kancherla Ravindranath realized the urgent need for a Liver transplant facility in India. Deeply touched by the plight of hundreds of patients' and inspired by his late Father's advice to come back to serve India, Dr. Ravindranath relinquished his very successful practice in UK and returned to India to establish Global Hospitals. Global Hospitals is India's leading and the fastest growing super specialty care and multi-organ transplantation hospital. Pioneers in performing transplantation surgeries, Global Hospitals has to its credit many trailblazing achievements made possible by combining research, teaching and patient care. Global Hospitals constantly strive for quality and innovation while excelling in advanced technology and modern facilities that are crucial to the delivery of high quality medical care, Global Hospital’s  doctors, nurses and technicians has indeed made Global Hospitals a place of highly specialized expertise.

Mr. C. Chandrasekhar, Executive Director - Marketing, Global Hospitals Group received the award at the hand of Mayank Gandhi, Member, National Executive, Aam Admi Party in the presence of Satya Brahma, Chairman & Editor-In-Chief of the Pharmaleaders Group